Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. (Q46949363)
Jump to navigation
Jump to search
scientific article published on 5 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. |
scientific article published on 5 November 2013 |
Statements
1 reference
Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. (English)
1 reference
Battsetseg Batchuluun
1 reference
Toyoshi Inoguchi
1 reference
Noriyuki Sonoda
1 reference
Shuji Sasaki
1 reference
Tomoaki Inoue
1 reference
Yoshinori Fujimura
1 reference
Daisuke Miura
1 reference
Ryoichi Takayanagi
1 reference
5 November 2013
1 reference
1 reference
232
1 reference
156-164
1 reference
1
1 reference
Identifiers
1 reference